Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of highly potent human glutaminyl cyclase (QC) inhibitors as anti-Alzheimer's agents by the combination of pharmacophore-based and structure-based design
Nguyễn Văn Mạnh, Van-Hai Hoang, Van T.H. Ngo, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113819-113819
Closed Access | Times Cited: 12

Showing 12 citing articles:

Targeting QPCTL: An Emerging Therapeutic Opportunity
Lei Yu, Yaoliang Sun, Long-Yan Xie, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 2
Therapeutic potential of glutaminyl cyclases: Current status and emerging trends
Judite R.M. Coimbra, Paula I. Moreira, Armanda E. Santos, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 10, pp. 103644-103644
Open Access | Times Cited: 22
Benzimidazole and Benzoxazole Derivatives Against Alzheimer's Disease
Nagihan Faydalı, Özlem Temiz‐Arpacı
Chemistry & Biodiversity (2024) Vol. 21, Iss. 6
Closed Access | Times Cited: 7
Functions of glutaminyl cyclase and its isoform in diseases
Yue Liu, Yufeng Shi, Ping Wang
Visualized Cancer Medicine (2023) Vol. 4, pp. 1-1
Open Access | Times Cited: 11
Analysis of the Molecular Mechanism of Punicalagin in the Treatment of Alzheimer’s Disease by Computer-Aided Drug Research Technology
Ping Xu, Liang Xu, Shuyun Huang, et al.
ACS Omega (2022) Vol. 7, Iss. 7, pp. 6121-6132
Open Access | Times Cited: 17
Synthesis and Evaluation of a Novel PET Radioligand for Imaging Glutaminyl Cyclase Activity as a Biomarker for Detecting Alzheimer’s Disease
William J. Behof, Justin R. Haynes, Clayton A. Whitmore, et al.
ACS Sensors (2024) Vol. 9, Iss. 5, pp. 2605-2613
Open Access | Times Cited: 2
Discovery of potent indazole-based human glutaminyl cyclase (QC) inhibitors as Anti-Alzheimer's disease agents
Nguyễn Văn Mạnh, Van-Hai Hoang, Van T.H. Ngo, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114837-114837
Closed Access | Times Cited: 7
Discovery of Tryptophan‐tetrahydroisoquinoline Derivatives as Multifunctional Agents for Treatment of Alzheimer's Disease
Xin Lü, Yijun Liu, Nan Qin, et al.
Chinese Journal of Chemistry (2022) Vol. 40, Iss. 15, pp. 1821-1830
Closed Access | Times Cited: 5
Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease
Daoyuan Chen, Qingxiu Chen, Xiaofei Qin, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 2
Discovery of potential scaffolds for glutaminyl cyclase inhibitors: Virtual screening, synthesis, and evaluation
Qingqing Zhou, Jiaxin Cai, Feixia Qin, et al.
Bioorganic & Medicinal Chemistry (2023) Vol. 97, pp. 117542-117542
Open Access | Times Cited: 2
Recent Advances in the Search for Effective Anti-Alzheimer’s Drugs
Martyna Ogos, Dorota Stary, Marek Bajda
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 157-157
Open Access
Computational Methods for the Design and Development of Glutaminyl Cyclase Inhibitors in Alzheimer’s Disease
Kiran Bagri, Ashwani Kumar, Parvin Kumar, et al.
Neuromethods (2023), pp. 383-403
Closed Access | Times Cited: 1
Page 1

Scroll to top